These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2109544

  • 21. Should all sexually active young women in Hungary be screened for Chlamydia trachomatis?
    Nyári T, Woodward M, Kovács L.
    Eur J Obstet Gynecol Reprod Biol; 2003 Jan 10; 106(1):55-9. PubMed ID: 12475582
    [Abstract] [Full Text] [Related]

  • 22. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
    Norman JE, Wu O, Twaddle S, Macmillan S, McMillan L, Templeton A, McKenzie H, Noone A, Allardice G, Reid M.
    BJOG; 2004 Nov 10; 111(11):1261-8. PubMed ID: 15521872
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Chlamydia trachomatis screening in the adolescent population.
    Holder DW, Woods ER.
    Curr Opin Pediatr; 1997 Aug 10; 9(4):317-24. PubMed ID: 9300187
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The usefulness of screening for chlamydial trachomatis infection with cervical mucus leukocyte esterase.
    el-Shourbagy M, Diab KM, Abdalla MY, el-Salam MA, Mohasb SH.
    J Obstet Gynaecol Res; 1998 Feb 10; 24(1):21-5. PubMed ID: 9564101
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cost-effectiveness of screening women at moderate risk for genital infections caused by Chlamydia trachomatis.
    Nettleman MD, Jones RB.
    JAMA; 1988 Jul 08; 260(2):207-13. PubMed ID: 3133496
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparing cost effectiveness of screening women for Chlamydia trachomatis in systematic and opportunistic approaches.
    Postma MJ, Welte R, van den Hoek JA, Morré SA.
    Sex Transm Infect; 2002 Feb 08; 78(1):73-4. PubMed ID: 11872873
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Point-of-care management of urogenital Chlamydia trachomatis via Gram-stained smear analysis in male high-risk patients. Diagnostic accuracy and cost-effectiveness before and after changing the screening indication at the STI Clinic in Amsterdam.
    Bartelsman M, van Rooijen MS, Alba S, Vaughan K, Faber WR, Straetemans M, de Vries HJ.
    Sex Transm Infect; 2015 Nov 08; 91(7):479-84. PubMed ID: 25855625
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Should asymptomatic men be included in chlamydia screening programs? Cost-effectiveness of chlamydia screening among male and female entrants to a national job training program.
    Blake DR, Quinn TC, Gaydos CA.
    Sex Transm Dis; 2008 Jan 08; 35(1):91-101. PubMed ID: 18217229
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.